Saving 100 million lives, one trial at a time

We view the clinical researchers who use Medrio as partners in the goal we both share: to live in a stronger, healthier world.

Our Mission

At Medrio, our purpose is to save 100 million lives by providing clinical researchers with the tools necessary to chase the next breakthrough in public health. Our success is defined by our customers’ ability to accelerate their research, eliminate hurdles, and maximize their return on investment. We’re committed to partnering with sponsors and CROs in early phase pharma, medical device, and diagnostics clinical research along their journey to medical discovery.

4,500+ studies

Faster studies across the globe in all phases and industries

98% Customer Satisfaction

Consistently meeting and exceeding your demands

600+ Customers

Join the organizations chasing the next breakthrough

Accelerate your research. Enhance data quality. Improve patient safety.

Medrio: supporting clinical trial data collection with intuitive and proven eClinical tools since 2005.

Meet the Medrio Team

Mike Novotny Headshot
Mike Novotny
Founder and Chief Executive Officer

Mike Novotny is the founder and CEO of Medrio. Mr. Novotny applies 20 years of experience in research and software to his eClinical SaaS vision. Prior to founding Medrio, Mr. Novotny was president of Ninaza, an EDC software company, and had previously held roles as a research associate at the U.N. and a manager of the fraud database at VISA. He holds a BA from Stanford University and an MBA from Columbia University. Mr. Novotny founded Medrio in 2005 in San Francisco.

Read Bio >
Christina Hughes Headshot
Christina Hughes
Chief Operating Officer

英皇棋牌Christina Hughes is the Chief Operating Officer of Medrio. Christina has over 20 years of experience in the clinical trials industry focused on delivering high quality solutions through the innovative use of technology. Prior to joining Medrio, Ms. Hughes held executive positions at Bracket (now Signant Health), AiCure, and ERT. Ms. Hughes holds a BS from Yale University and an MBA from University of Pennsylvania’s The Wharton School.

Read Bio >
Nathan Weems Headshot
Nathan Weems
Chief Financial Officer

英皇棋牌Nathan has accrued over 13 years of operational excellence in management roles spanning finance, business development, and marketing, most recently serving as Sr. Director of Finance at Natera, a public Bay Area biotech company. Earlier experience includes tenure at a top Wall Street investment bank and Big-4 accounting firm. Nathan brings expertise in accounting, due diligence, market research, fund raising and investor relations. He holds a BA from the University of Southern California and an MBA from Wharton. When his HP 12C is not within reach, you can usually find Nathan on two wheels or two skis exploring the outdoors with his family.

Read Bio >
Fred Martin Headshot
Fred Martin
Chief Product Officer

英皇棋牌Fred Martin has built a career in healthcare over the course of nearly two decades, and has developed healthcare systems, BI/Analytics solutions, workflow tools for hospitals, and more. He has served in Director of VP positions at companies including PointClickCare, Press Ganey, and Premiere Healthcare Alliance. He brings broad experience in user-centered design and bridging cosumer-centric front-end web applications and technology infrastructures to his role at Medrio. Fred holds a MBA from the University of Michigan, Ann Arbor; a MILR from Cornell University; and a BA from the University of Colorado, Boulder.

Read Bio >
Mike Novotny Headshot
Mike Novotny
Board Member, Founder and Chief Executive Officer of Medrio

Mike Novotny is the founder and CEO of Medrio. Mr. Novotny applies 20 years of experience in research and software to his eClinical SaaS vision. Prior to founding Medrio, Mr. Novotny was president of Ninaza, an EDC software company, and had previously held roles as a research associate at the U.N. and a manager of the fraud database at VISA. He holds a BA from Stanford University and an MBA from Columbia University. Mr. Novotny founded Medrio in 2005 in San Francisco.

Read Bio >
Brad Sloan Headshot
Brad Sloan
Medrio Board Member, Managing Partner, Questa Capital

Brad Sloan has been actively involved in the healthcare space for 20 years and specializes in investments in the healthcare information technology and healthcare services sectors. Prior to co-founding Questa, Brad was a senior investment professional at Parthenon Capital Partners, a growth oriented private equity firm, where he helped lead the healthcare investment practice. Prior to Parthenon, Brad worked at Broadlane, Inc., a healthcare technology company, where he was a member of the Executive Management Committee. Brad previously worked in a variety of healthcare investment roles at MTS Health Partners and Evercore Partners. Brad started his career in the Healthcare Investment Banking Group at Bear, Stearns & Co. Inc.

Read Bio >
Dave Lipscomb Headshot
Dave Lipscomb
Medrio Board Member, Founder and Former CIO, NetSuite

英皇棋牌Dave Lipscomb brings great depth in software as a service (SaaS) to Medrio after spending 14 years at NetSuite, where he was a founding member in 1998. Holding the titles Senior Vice President of Engineering and Chief Information Officer, Mr. Lipscomb drove engineering, product management, and IT operations. Most recently, Mr. Lipscomb held the position of Senior Vice President of Customer Loyalty, focusing on customer retention and customer satisfaction. Under his leadership, NetSuite enabled thousands of customers worldwide to manage their business in real time, and the NetSuite service has achieved unprecedented uptime and reliability in the on-demand industry.

Read Bio >
Doug Engfer Headshot
Doug Engfer
Medrio Board Member, Founder and Former CEO, invivodata

英皇棋牌An entrepreneur from a long line of entrepreneurs, Doug Engfer has more than 25 years of executive leadership experience, focused on building productive organizations that expand their customers’ top-line revenue. Most recently, Doug co-founded invivodata (now part of ERT), serving as President, CEO, and Board Chair. invivodata permanently changed pharmaceutical clinical research by pioneering the direct collection of valid, reliable patient self-reported data. Before that, Doug founded The Windward Group (now part of Nokia), a Silicon Valley software development services firm.

Read Bio >
Emily Drabant Conley, Ph.D. Headshot
Emily Drabant Conley, Ph.D.
Medrio Board Member, VP of Business Development, 23andMe

英皇棋牌Emily Drabant Conley, Ph.D. joined 23andMe in 2010 and serves as Vice President, Business Development. She has a passion for disrupting healthcare inefficiencies and creating new markets. Dr. Conley is responsible for setting company strategy, including leveraging and monetizing 23andMe’s 10M person database. Dr. Conley oversees business development, corporate development, and alliance management, and has a proven track record of successful deal closure spanning partners in pharma, biotech, digital health, big data, retailers, CPG, traditional healthcare, and academia. She also is deeply involved in company growth, including raising capital from VCs, growth funds, and strategic investors.

Dr. Conley is a 23andMe company spokesperson and has multiple national TV appearances. She has been featured on Bloomberg, NPR, FOX, Forbes, CBS, and the TODAY Show, among others.

Prior to 23andMe, Dr. Conley spent 10 years conducting research that combined genetics and neuroimaging to understand neuropsychiatric disease. She was a Research Fellow at the National Institute of Mental Health and is co-author on more than 30 academic publications.

英皇棋牌Dr. Conley serves on the Board of TMRW, which has created the first robotic automation platform for modernizing the storage of embryos for IVF. She formerly served on the Board of Lesbians Who Tech, an organization dedicated to increasing diversity representation in the technology industry and the UCSF Alliance Health Project, a clinic which provides services to the LGBT and HIV-affected communities in San Francisco.

英皇棋牌She received her Ph.D. in Neuroscience from Stanford University School of Medicine, where she held fellowships from the National Science Foundation and Department of Defense. She graduated summa cum laude from Vanderbilt University with a B.A. in Psychology and Business.

Read Bio >
Ryan Drant Headshot
Ryan Drant
Medrio Board Member, Founder and Managing Partner, Questa Capital

Ryan Drant has been actively investing in healthcare since 1996. He specializes in investments in the medical device, healthcare services, healthcare information technology and specialty pharma sectors. Ryan has been named four times to the Forbes Midas List of best venture capital investors. Prior to founding Questa, Ryan was a General Partner at New Enterprise Associates (NEA). He led the firm’s global healthcare investing practice and served as a member of NEA’s four-person management committee. Previously, Ryan was with the Health Care Investment Banking Group of Alex. Brown & Sons and Arthur Andersen & Co.

Read Bio >

Careers at Medrio

Medrio is a San Francisco based company providing software for clinical research. As a fast-growing company, Medrio is always looking for talented people to join our team. Please send general inquiries to careers@chinametalprocessing.com英皇棋牌 or apply directly for our current openings:

Customer Success

News & Events

Recent News

MAY 2019
MMS Holdings Leverages Medrio to Accelerate Clinical Trial Process for Study Sponsors Through New Contract
APRIL 2019
Medrio Launches Enhanced Channel Partner Program to Facilitate Success for CROs
APRIL 2019
Quartesian LLC Executes Multi-Year Enterprise Agreement with Medrio
FEB 2019
Innovaderm Executes Multi-Year Enterprise Agreement with Medrio
FEB 2019
Medrio Reports Significant Growth in 2018 after a Year of Enhancements to the Customer Experience
MAY 2018
Altasciences Clinical Research Joins the Medrio Partner Program
APRIL 2018
Medrio Leads the Way to Paperless Clinical Trials with New eSource Features
APRIL 2018
Medrio Delivers on Commitment to Customer Success with Launch of New Online Resource - chinametalprocessing.community
FEB 2018
Medrio Announces Accelerated Global Expansion on the Heels of a Successful 2017
APRIL 2017
Non-Profit MAPS to Utilize Full Range of Medrio Functionality for Pivotal PTSD Study